US Patent Issued to Kuleon on April 15 for "Neuroplastogens and non-hallucinogenic serotonin 5-HT2A receptor modulators" (Washington Inventor)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,275,701, issued on April 15, was assigned to Kuleon LLC (Seattle).

"Neuroplastogens and non-hallucinogenic serotonin 5-HT2A receptor modulators" was invented by David Gilles (Tacoma, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Hallucinogenic and non-hallucinogenic serotonin receptor agonists are disclosed herein in addition to methods of making and using the same."

The patent was filed on June 13, 2024, under Application No. 18/741,888.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=P...